We are live on ! Find out more
NPCE icon

Neuropace

80 hedge funds and large institutions have $268M invested in Neuropace in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

9.81% more ownership

Funds ownership: 68.62%78.43% (+9.8%)

7% more capital invested

Capital invested by funds: $251M → $268M (+$16.8M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less call options, than puts

Call options by funds: $209K | Put options by funds: $226K

18% less funds holding

Funds holding: 9880 (-18)

64% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 28

Holders
80
Holders Change
-18
Holders Change %
-18.37%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
33
Reduced
21
Closed
28
Calls
$209K
Puts
$226K
Net Calls
-$17K
Net Calls Change
-$34.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Carson Wealth (CWM LLC)
76
Carson Wealth (CWM LLC)
Nebraska
$2K -$490 -52 -19%
SCM
77
Sterling Capital Management
North Carolina
$598
Nisa Investment Advisors
78
Nisa Investment Advisors
Missouri
$546 -$207 -22 -29%
SIS
79
Sound Income Strategies
Florida
$227
SS
80
SBI Securities
Japan
$217 -$1.59K -169 -89%
DM
81
Deerfield Management
New York
-$5.57M -500,000 Closed
Lord, Abbett & Co
82
Lord, Abbett & Co
New Jersey
-$4.46M -400,743 Closed
CSS
83
Cubist Systematic Strategies
Connecticut
-$1.07M -95,618 Closed
YIH
84
Y-Intercept (HK)
Hong Kong
-$600K -53,894 Closed
Jacobs Levy Equity Management
85
Jacobs Levy Equity Management
New Jersey
-$579K -51,972 Closed
GCM
86
Ghisallo Capital Management
Massachusetts
-$557K -50,000 Closed
JF
87
Jump Financial
Illinois
-$451K -40,474 Closed
Arrowstreet Capital
88
Arrowstreet Capital
Massachusetts
-$353K -31,687 Closed
Susquehanna International Group
89
Susquehanna International Group
Pennsylvania
-$275K -29,197 Closed
PP
90
PDT Partners
New York
-$264K -23,695 Closed
FAIM
91
Financial Advocates Investment Management
Washington
-$256K -23,000 Closed
BC
92
Birchview Capital
Vermont
-$183K -16,442 Closed
CC
93
Centiva Capital
New York
-$177K -15,857 Closed
IIM
94
INTECH Investment Management
Florida
-$162K -14,572 Closed
PTC
95
Petrus Trust Company
Texas
-$160K -14,384 Closed
EGM
96
Engineers Gate Manager
New York
-$152K -13,609 Closed
GCM
97
Graham Capital Management
Connecticut
-$146K -13,065 Closed
LP
98
Longaeva Partners
Illinois
-$122K -10,933 Closed
QT
99
Quantbot Technologies
New York
-$34.8K -3,128 Closed
Simplex Trading
100
Simplex Trading
Illinois
-$17.9K -1,895 Closed

NPCE Hedge Fund Activity: Q3 2025 in Review

80 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q3 2025, worth a combined $268M — up 6.7% from $251M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NPCE and 10 opened new positions — a net loss of 18 holders — while 21 trimmed existing stakes and 33 added.

The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $29.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.57M sold.

  • 80 institutional investors held Neuropace (NPCE) as of Q3 2025, down from 98 in Q2 2025.
  • Funds reported $268M of Neuropace stock for Q3 2025, up 6.7% quarter-over-quarter.
  • 10 funds opened new Neuropace positions in Q3 2025 and 28 closed out, a net change of -18 holders.
  • The largest Neuropace buyer in Q3 2025 was Polar Capital Holdings, an estimated $29.2M added.
  • The largest Neuropace seller in Q3 2025 was Deerfield Management, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2025.